|
Non-synonymous mtDNA sequence changes detected in CADASIL patients |
|||||||
| Nucleotide substitution |
Amino Acid substitution |
Base substitution type |
Location |
Hetero-plasmy (%) |
Interspecies conservation |
PolyPhen prediction |
Pathogenicity prediction |
|
|
|||||||
| 3851 C>G |
A182G |
Transversion |
TM domain of ND1 gene |
N/A |
Moderate |
Benign |
Non-pathologic |
| 14113 T>C |
F593L |
Transition |
TM domain of ND5 gene |
N/A |
Low |
Benign |
Non-pathologic |
| 14171 A>G |
I168T |
Transition |
TM domain of ND6 gene |
N/A |
Low |
Benign |
Non-pathologic |
| 14966 A>C |
N74H |
Transversion |
Outside the functional domain of CYTB gene |
N/A |
High |
Benign |
Non-pathologic |
| 15048 G>C |
G101A |
Transversion |
Outside the functional domain of CYTB gene |
N/A |
Moderate |
Benign |
Non-pathologic |
|
Base substitution type – Transversion = A mutation in which a purine/pyrimidine replaces a pyrimidine/purine base pair or vice versa [G:C > T:A or C:G, or A:T > T:A or C:G]; Transition = A mutation in which a purine/pyrimidine base pair is replaced with a base pair in the same purine/pyrimidine relationship [A:T > G:C or C:G > T:A]. Interspecies conservation was assessed using PolyPhen [21] which determines interspecies conservation for an altered amino acid by performing alignment with all available amino acid sequences for other species. Pathogenicity prediction = A sequence variant was considered potentially pathogenic if it satisfied all the condition detailed in methods. None of above listed non-synonymous sequence changes were found in ethnicity-matched controls (n = 159). | |||||||
Abu-Amero et al. BMC Research Notes 2008 1:16 doi:10.1186/1756-0500-1-16 |
|||||||